TeselaGen is Partnering with SynBioBeta
SynBioBeta as the ultimate intersection: where cutting-edge research meets industry innovation, and where leaders launch their journeys.

TeselaGen is partnering with SynBioBeta to offer a special community rate for its network. Join the next wave of agentic biotech startups and the operators building AI-native R&D stacks, where autonomous design–build–test–learn loops are moving from concept to production. From foundation models and virtual cells to AI-designed molecules entering real pipelines, this is where software-defined biology becomes executable. Hear leaders from Xaira, GSK, Novo Nordisk, NVIDIA, OpenAI, and the startups redefining therapeutics, materials, and longevity. This is where AI-powered biology gets built, orchestrated, and deployed.

TeselaGen Community: Exclusive Discount Access
TeselaGen x SynBioBeta: a special rate to join the founders, thought leaders, and investors building the future of AI-powered biology.
Eric Schmidt
Former CEO

Emily LeProust
Founder & CEO
Jacob Glanville
Founder & CEO

TeselaGen Biotechnology SynBioBeta Partnership
One day passes available to our customers





